TRAX: First Tracks Biotherapeutics, Inc.
Performance
TRAX +167.20%
Watchlist
Select an item
Summary
TRAX at a glance
TRAX returned +167.20% since Apr 20, 2026. Its worst drop since then was -36.16%, smaller than 44% of stocks on Redstone, and its Sharpe ratio of 1.97 beats 97% of stocks on Redstone. It hasn't paid a dividend since it listed.
Current Drawdown
0.00%
Rolling Volatility
77.18%
Actions
Metrics
Risk Indicators*
Alpha215.75%
Beta2.14x
Sharpe1.97
Sortino4.36
Omega1.48
Calmar4.62
Martin12.16
Profile
About TRAX
First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $2.1B
- Listed
- Apr 2026
- Headquarters
- San Diego, CA
Comparisons